Graham McLean
Follow
Get notifications in MyBN when activity occurs.
Graham McLean
Non-Executive Director, Non-Executive Chairman / Universal Biosensors Inc
Most Notable Role
Graham McLean has financial and commercial experience within the medical technology sector. He also has an understanding of North America and UK listed entities having worked in finance and operations roles for international companies.
He has worked with NYSE-listed Stryker for 16-years and has medical device and healthcare experience. At Stryker, Mr McLean held several senior positions including as president for Japan, Australia/New Zealand and Asia Pacific when he was based in Singapore and Hong Kong. Mr McLean was also responsible for transforming Asia Pacific, including restructuring their China distribution. Prior to Stryker, Mr McLean held senior finance and operational roles in Asia and Europe including international consumer brands Lion Nathan, Smiths Snackfoods (Pepsi), McVities (United Biscuits), United Distillers (Guinness) and Unilever.
He is an advisor to Bain & Company and GLG, and a board member of Suicide Prevention Australia.
Mr McLean holds a Bachelor of Science Geography from Durham University, is a CPA, a Fellow of The Chartered Institute of Management Accountants, and a graduate of the Australian Institute of Company Directors.
He has worked with NYSE-listed Stryker for 16-years and has medical device and healthcare experience. At Stryker, Mr McLean held several senior positions including as president for Japan, Australia/New Zealand and Asia Pacific when he was based in Singapore and Hong Kong. Mr McLean was also responsible for transforming Asia Pacific, including restructuring their China distribution. Prior to Stryker, Mr McLean held senior finance and operational roles in Asia and Europe including international consumer brands Lion Nathan, Smiths Snackfoods (Pepsi), McVities (United Biscuits), United Distillers (Guinness) and Unilever.
He is an advisor to Bain & Company and GLG, and a board member of Suicide Prevention Australia.
Mr McLean holds a Bachelor of Science Geography from Durham University, is a CPA, a Fellow of The Chartered Institute of Management Accountants, and a graduate of the Australian Institute of Company Directors.
Lists and Charts
Total Shareholder Return as at 28/06/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 49th | Arovella Therapeutics | 180% | 116% |
| 109th | Nyrada Inc | 111% | |
| 434th | CleanSpace Holdings | 25% | |
| 1418th | Hexima | -48% | |
| 1616th | Spark Infrastructure Group | -62% | -32% |
1769 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Roles
Year started and most recent title
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 766th |  | CleanSpace Holdings | $12.1m |
| 973rd | | Hexima | $1.5m |
| 974th | | Arovella Therapeutics | $1.5m |
| 976th | | Nyrada Inc | $1.4m |
| 977th | | Spark Infrastructure Group | $1.4m |
1333 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Person Activity
| NEW ROLE: Non-Executive Director, Non-Executive Chairman, Universal Biosensors Inc | 08 Aug 2024 |
| NEW ROLE: Non-Executive Director, Fisher & Paykel Healthcare Corporation | 25 Jul 2024 |
| NEW ROLE: Non-Executive Director, CleanSpace Holdings | 05 Feb 2022 |
